首頁 › 前列腺癌 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 前列腺癌 臨床試驗
44 項針對 前列腺癌 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 距離 13 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 距離 22 英里
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
招募中1 期
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
招募中觀察性研究
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · 距離 5 英里
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- MidLantic urology, Bala-Cynwyd · 距離 5 英里
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
招募中2/3 期
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
招募中2 期
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
招募中1/2 期
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
招募中
- MidLantic Urology, Bala-Cynwyd · 距離 5 英里
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Christiana Care Health System-Concord Health Center, Chadds Ford · 距離 23 英里
- Christiana Care Health System-Wilmington Hospital, Wilmington · 距離 25 英里
A Study of Tarlatamab for People With Prostate Cancer
招募中2 期
- Thomas Jefferson University Hospital, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Thomas Jefferson University, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
招募中2 期
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
招募中1 期
- Thomas Jefferson University, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
招募中3 期歡迎健康志工
- MidLantic Urology, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Investigative Site #109, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 距離 23 英里
- Christiana Care Health System-Wilmington Hospital, Wilmington · 距離 25 英里
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
招募中1 期
- MidLantic Urology, Bala-Cynwyd · 距離 5 英里
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
招募中1 期
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
招募中1/2 期
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
招募中2 期
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
招募中2 期
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
招募中觀察性研究
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
招募中觀察性研究歡迎健康志工
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
招募中觀察性研究歡迎健康志工
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
招募中
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
招募中2/3 期
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
招募中1/2 期
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
招募中2 期
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
招募中1 期
- MidLantic Urology, Bala-Cynwyd · 距離 5 英里
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
招募中4 期
- Albert Einstein Healthcare Network, Philadelphia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Christiana Care Health System-Concord Health Center, Chadds Ford · 距離 23 英里
- Christiana Care Health System-Wilmington Hospital, Wilmington · 距離 25 英里
Prostate Tissue BioBank
招募中觀察性研究
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
招募中
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Philadelphia
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
- Dallas, TX36 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
- 胰臟癌26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。